Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We describe the docking of selected steroidal and non-steroidal estrone sulphatase inhibitors, including the Phase I clinical trial candidate 667COUMATE (6), into the active site of human carbonic anhydrase II (hCA II). The docking scores are compared with the inhibition of hCA II and show good correlation with biological activity.


Journal article


Bioorg Med Chem Lett

Publication Date





863 - 865


Binding Sites, Carbonic Anhydrase II, Carbonic Anhydrase Inhibitors, Coumarins, Estrone, Humans, Inhibitory Concentration 50, Models, Molecular, Steroids, Structure-Activity Relationship, Substrate Specificity, Sulfatases, Sulfonamides, Sulfonic Acids